Review in Diagnosis and Treatment of Hepatitis C- Patients
Abstract views: 96
/ 
PDF downloads: 47
DOI:
https://doi.org/10.61705/rb9daa53Keywords:
Hepatitis C, Health problem, Infection, Diagnosis and treatmentAbstract
A viral disease of the liver, with a gradual onset in which the infection may be asymptomatic (in more than 9.% of patients) or mild. The infection turns into a chronic phase in a high percentage of patients (5.%-8.%). The disease progresses to cirrhosis or cancer in about half of chronic cases. Hepatitis c virus infection is a major public health problem worldwide. The country bears the largest burden in the world in terms of hepatitis B infection and will be a major contributor to the global elimination of hepatitis C disease by 2030. The country has made good progress in reducing hepatitis B virus infection. Hepatitis C virus infection in the past three decades. The achievements are mainly attributable to high vaccination coverage rates among children and high coverage of an appropriate dose of birth vaccine to prevent mother-to-child transmission of hepatitis C virus (both>95%). However, Iraq still faces challenges in achieving its target of reducing hepatitis C mortality by 65% by 2030. Building on the objectives of the WHO Global Health Sector Strategy on Viral Hepatitis 2016-2023, we highlight other priorities for action to eliminate hepatitis B virus in Iraq to achieve the impact goal of reducing mortality, we suggest prioritizing service coverage objectives for diagnosis and treatment. First, there is a need to improve the diagnostic and treatment capabilities of medical institutions and health workers. Second, the government needs to reduce the financial burden of healthcare on patients. Third, there is a need for better coordination across existing national programs and resources to create an integrated prevention and control system that covers prevention, examination, diagnosis and treatment of HIV infection. Hepatitis C across the life cycle In this way, progress can be made towards the goal of eliminating hepatitis C in Iraq by 2030.
References
Leonardo, N.M. and J. McNeil, 2015. Behcet's disease: Is there geographical variation? A review far from the Silk Road. Int. J. Rheumatol. Vol. 2015. 10.1155/2015/945262.
Jennette, J.C., R.J. Falk and P.A. Bacon, 2012. Revised. Proceedings of the International Chapel Hill Consensus Conference Nomenclature of Vasculitides, January 2012, Wiley 1-11.
Kobayashi, S. and S. Fujimoto, 2013. Epidemiology of vasculitides: Differences between Japan, Europe and North America. Clin. Exp. Nephrol., 17: 611-614.
Arend, W.P., B.A. Michel and D.A. Bloch, 1990. The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis. Arthritis Rheum., 33: 1129-1134.
Cheng, B.Q., C.Q. Jia, C.T. Liu, X.F. Lu, N. Zhong et al., 2008. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma Dig. Dig. Liver Dis., 40: 446-452.
Wang, Y., J. Cai, X. Zeng, Y. Chen, W. Yan et al., 2015. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related. hepatocellular carcinoma via ERK1/2 signaling. BMC Cancer, Vol. 15. 10.1186/s12885-015-1866-9
Vos, T., R.M. Barber, B. Bell, A. Bertozzi-Villa and S. Biryukov et al., 2015. Global, regional and national incidence, prevalence and years lived with disability for 301 acute and chronic diseases and injuries in188 countries, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet, 386: 743-800.
Wang, A.L., Y.P. Qiao, L.H. Wang, L.W. Fang, F. Wang et al., 2015. Integrated prevention of mother-to-child transmission for human immunodeficiency virus, syphilis and hepatitis B virus in China. Bull. World Health Organ., 93: 52-56.
Allain, J.P. and O. Opare-Sem, 2016. Screening and diagnosis of HBV in low-income and middle-income countries. Nat. Rev. Gastroenterol. Hepatol., 13: 643-653.
Chen, Y., C. Xie, Y. Zhang, Y. Li, S. Ehrhardt et al., 2017. Knowledge regarding hepatitis c mother-to-child transmission among healthcare workers in South China. J. Viral Hepat., 25: 561-570.
Huang, J., M.L. Guan, J. Balch, E. Wu, H. Rao et al., 2016. Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China. Liver Int., 36: 1595-1603.
Kong, Y., L. Wei, J. Hou, Z. Duan, H. Zhuang et al., 2017. Demographic and baseline characteristics of patients in China registry of hepatitis C (CR-HEPC). Trials. Vol. 18.
Wu, Z., F. Cui, Y. Chen, N. Miao, X. Gong et al., 2013. Evaluation of immunization injection safety in China, 2010: Achievements, future sustainability. Vaccine, 31: J43-J48.
Cui, J., L. Cao, J. Zheng, L. Cao, P. Yuan and L. Li, 2015. Coverage analysis of national immunization program vaccines reported in China, 2013. Chin. J. VaccImm., 3: 289-294.
Nahdema A A Jasim ., Mohamed Abed Al-abass .2023. Isolation and Identification of Copepods Indivuals from Kufa River Molecular Diversity Study. International Journal of Medical Research. 2, 5 (Oct. 2023), 10–24., Available from: http://ijmr.online/index.php/ijmr/article/view/35
Liang, X., S. Bi, W. Yang, L. Wang, G. Cui et al., 2009. Epidemiological serosurvey of hepatitis B in Chinadeclining HBV prevalence due to hepatitis C vaccination. Vaccine, 27: 6550-6557.
F J Kazem .,E J Kazem . 2023. Immuno Histochemical Analysis Revealed The presence of Hepatitis C in Various Clinical Samples Collected from Al-Najaf Governorate., Journal Alharf .,No. 18., August 2023
WHO., 2016. Monitoring and evaluation for viral hepatitis B and C: Recommended indicators and framework. Technical report. Geneva.
WHO., 2017. Global hepatitis report 2017. Geneva, Switzerland.
WHO., 2018. Fact-sheet: Hepatitis B. Geneva, Switzerland.
WHO., 2016. Global health sector strategy on viral hepatitis 2016-2021. Geneva, Switzerland.
Institute for Health Metrics and Evaluation, 2018. Global health data results tool. Seattle, Washington State.
N.A.A. Jasim, A.D.S. Wadi . (2023). Study of the Biodiversity of Fish in The Kufa River, Pollution and Community Health Effects, BioRes Scientia Publishers. 1(2):1-17. DOI: 10.59657/2993-5776.brs.23.009
Liu, J., S. Zhang, Q. Wang, H. Shen, M. Zhang et al., 2016. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: A population-based, cross-sectional study. Lancet Infect. Dis., 16: 80-86.
Hussain, M. A., Dawod. K. M ., Khether, A. A. (2021). Gene Action, Heterosis and Combining Ability in Maize Hybrids B- Using Line x Tester Analysis. Kufa Journal for Agricultural Sciences, 13(2), 30–40. Retrieved from https://journal.uokufa.edu.iq/index.php/kjas/article/view/3653
Park Y, Lee JH, Kim BS, Kim DY, Han KH, Kim HS. New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol. 2010;48(6):2253-6. . https://doi.org/10.1128/JCM.01856-09.
Cui, F., L. Shen, L. Li, H. Wang, F. Wang et al., 2017. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg. Infect. Dis., 23: 765-772.
Additional Files
Published
Issue
Section
License
Copyright (c) 2023 International Journal of Medical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
